BG
Bahl & Gaynor Portfolio holdings
AUM
$19.8B
This Quarter Return
+0.89%
1 Year Return
+17.27%
3 Year Return
+58.16%
5 Year Return
+110.76%
10 Year Return
+270.98%
AUM
$5.29B
AUM Growth
–
Cap. Flow
+$5.29B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
28.42%
Holding
359
New
359
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Procter & Gamble
PG
|
$323M |
| 2 |
Johnson & Johnson
JNJ
|
$166M |
| 3 |
McDonald's
MCD
|
$162M |
| 4 |
Intel
INTC
|
$132M |
| 5 |
Chevron
CVX
|
$130M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Consumer Staples | 16.23% |
| 2 | Technology | 15.85% |
| 3 | Healthcare | 14.87% |
| 4 | Energy | 12.38% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PX
26
DELISTED
Praxair Inc
PX
| $69.2M | 1.31% |
+600,832
| New | +$69.2M |
|
27
Accenture
ACN
$162B
| $66.6M | 1.26% |
+925,139
| New | +$66.6M |
|
28
AbbVie
ABBV
$372B
| $64.6M | 1.22% |
+1,561,746
| New | +$64.6M |
|
29
Analog Devices
ADI
$124B
| $63M | 1.19% |
+1,398,941
| New | +$63M |
|
30
Blackrock
BLK
$175B
| $63M | 1.19% |
+245,181
| New | +$63M |
|
31
Genuine Parts
GPC
$19.4B
| $56.2M | 1.06% |
+720,073
| New | +$56.2M |
|
32
Bristol-Myers Squibb
BMY
$96B
| $54.6M | 1.03% |
+1,222,496
| New | +$54.6M |
|
33
Abbott
ABT
$231B
| $54M | 1.02% |
+1,547,426
| New | +$54M |
|
34
Welltower
WELL
$113B
| $53.3M | 1.01% |
+794,875
| New | +$53.3M |
|
35
Amgen
AMGN
$155B
| $51M | 0.96% |
+517,284
| New | +$51M |
|
36
Walt Disney
DIS
$213B
| $49.6M | 0.94% |
+785,850
| New | +$49.6M |
|
37
Healthpeak Properties
DOC
$12.5B
| $49.6M | 0.94% |
+1,091,759
| New | +$49.6M |
|
38
Stryker
SYK
$150B
| $48.4M | 0.91% |
+747,784
| New | +$48.4M |
|
39
Southern Company
SO
$102B
| $47.9M | 0.91% |
+1,085,218
| New | +$47.9M |
|
40
Cullen/Frost Bankers
CFR
$8.3B
| $46.2M | 0.87% |
+691,275
| New | +$46.2M |
|
41
Dover
DOV
$24.5B
| $44.6M | 0.84% |
+574,421
| New | +$44.6M |
|
42
Scotiabank
BNS
$77.6B
| $43.6M | 0.82% |
+813,569
| New | +$43.6M |
|
43
Baxter International
BAX
$12.7B
| $43.4M | 0.82% |
+626,516
| New | +$43.4M |
|
44
NextEra Energy, Inc.
NEE
$148B
| $43M | 0.81% |
+528,175
| New | +$43M |
|
45
Ecolab
ECL
$78.6B
| $42.2M | 0.8% |
+495,013
| New | +$42.2M |
|
46
AT&T
T
$209B
| $42.1M | 0.8% |
+1,189,541
| New | +$42.1M |
|
47
GSK
GSK
$79.9B
| $40.7M | 0.77% |
+814,787
| New | +$40.7M |
|
48
Becton Dickinson
BDX
$55.3B
| $40M | 0.76% |
+405,221
| New | +$40M |
|
49
BCE
BCE
$23.3B
| $39.7M | 0.75% |
+966,977
| New | +$39.7M |
|
50
Altria Group
MO
$113B
| $39.5M | 0.75% |
+1,128,578
| New | +$39.5M |
|